Fact sheet: Manulife Healthcare

Fund information

Fund name
Manulife Healthcare AA
Fund company manager
Manulife Global Fund
Fund type
SIB
Fund manager
Manulife Asset Management (US) LLC
since 27/06/2008
Fund objective
The sub-fund aims to provide medium to long term capital growth for those who hold a long term investment view and who are prepared to accept significant fluctuations in the value of their investments in order to achieve long term returns. It is intended that the investments will be made on a diversified basis. The underlying investment portfolio will mainly consist of equity-related investments and equities of companies in healthcare and related industries globally and which are listed on any stock exchange. The sub-fund may invest in companies which derive a significant portion of their earnings from medical and pharmaceutical products and services. The remaining assets of the sub-fund may include bonds, deposits and other investments.
Benchmark
MSCI World Healthcare
Investment style
Growth
Investment method
Shares

Quick stats

1 Year return

5.68 %

1 Year rank in sector

18/29

Sector

FO Equity - Pharma Health & Biotech

Yield
-
Fund size

£ 295.4 m

FE Risk score

125

NAV
-
Discount/Premium
-
Gearing
-

Top in sector

Holdings snapshot

  • USA
    64.77%
  • Switzerland
    7.34%
  • UK
    7.14%
  • Ireland
    5.43%
  • Germany
    5.21%
  • Pharmaceuticals
    46.42%
  • Biotechnology/Medical
    26.52%
  • Healthcare & Medical Products
    15.67%
  • Health Care
    7.9%
  • Cash & Cash Equivalents
    1.98%
  • US Equities
    64.77%
  • Swiss Equities
    7.34%
  • UK Equities
    7.14%
  • Irish Equities
    5.43%
  • German Equities
    5.21%

Performance vs. Sector

Cumulative performance

1m6m1y3y5y
Fund4.43 %8.91 %5.68 %16.01 %68.43 %
Sector2.44 %5.7 %6.98 %21.14 %97.17 %
Rank within sector7 / 3011 / 3018 / 2919 / 2719 / 23
Quartile th1 st2 nd3 rd3 rd4 th

Calendar performance

YTD-20172016201520142013
Fund15.1 %-7.31 %1.3 %19.2 %32.27 %
Sector15.5 %-9.92 %7.24 %28.08 %41.03 %
Rank within sector17 / 299 / 2924 / 2723 / 2415 / 23
Quartile th3 rd2 nd4 th4 th3 rd

Risk statistics

Alpha-0.68
Beta0.72
Sharpe0.1
Volatility12.14
Tracking error6.62
Information ratio-0.37
R-Squared0.84

Price movement

52 week high2.0358
52 week low1.6851
Current bid price0
Current offer price0
Current mid price2.0188

Holdings by region

  • 64.77% USA
  • 7.34% Switzerland
  • 7.14% UK
  • 5.43% Ireland
  • 5.21% Germany
  • 3.82% Denmark
  • 2.71% France
  • 1.98% Money Market
  • 1.23% Japan
  • 0.37% Others

Holdings by sector

  • 46.42% Pharmaceuticals
  • 26.52% Biotechnology/Medical
  • 15.67% Healthcare & Medical Products
  • 7.9% Health Care
  • 1.98% Cash & Cash Equivalents
  • 1.51% Food & Drug Retailers

Holdings by asset type

  • 64.77% US Equities
  • 7.34% Swiss Equities
  • 7.14% UK Equities
  • 5.43% Irish Equities
  • 5.21% German Equities
  • 3.82% Danish Equities
  • 2.71% French Equities
  • 1.98% Money Market
  • 1.23% Japanese Equities
  • 0.37% International Equities

Individual holdings

  • 6.11% JOHNSON & JOHNSON
  • 5.11% BIOGEN INC
  • 4.56% ALLERGAN PLC
  • 4.56% MERCK & CO INC(NEW)
  • 3.96% ROCHE HLDG AG
  • 3.94% GILEAD SCIENCES INC
  • 3.82% NOVO-NORDISK AS
  • 3.72% AMGEN INC
  • 3.7% PFIZER INC
  • 3.43% SHIRE PLC